-
Founded in:
1996-03-27 -
Country:
China -
Address:
No. 10, Tianzhu West Road, Area A, Tianzhu Airport Industrial Zone, Shunyi District, Beijing -
Tax NO.:
91110113600048921K -
Registered Funds:
630 million yuan -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Ambroxol hydrochloride |
Mucolytics can increase the secretion of respiratory mucosal serous glands, reduce mucous gland secretion, reduce sputum viscosity, promote the secretion of pulmonary surfactant, increase bronchial ciliary movement, and make sputum easier to cough up.
More
Mucolytics can increase the secretion of respiratory mucosal serous glands, reduce mucous gland secretion, reduce sputum viscosity, promote the secretion of pulmonary surfactant, increase bronchial ciliary movement, and make sputum easier to cough up. |
1.5mg | 23828-92-4 | 38 |
| Clenbuterol hydrochloride |
Selective beta-receptor agonists relax bronchial smooth muscles, enhance ciliary movement, dissolve mucus, and promote sputum discharge
More
Selective beta-receptor agonists relax bronchial smooth muscles, enhance ciliary movement, dissolve mucus, and promote sputum discharge |
1μg | 21898-19-1 | 14 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Ambroxol hydrochloride |
Mucolytics can increase the secretion of respiratory mucosal serous glands, reduce mucous gland secretion, reduce sputum viscosity, promote the secretion of pulmonary surfactant, increase bronchial ciliary movement, and make sputum easier to cough up.
More
Mucolytics can increase the secretion of respiratory mucosal serous glands, reduce mucous gland secretion, reduce sputum viscosity, promote the secretion of pulmonary surfactant, increase bronchial ciliary movement, and make sputum easier to cough up. |
23828-92-4 | 38 | |
| Clenbuterol hydrochloride |
Selective beta-receptor agonists relax bronchial smooth muscles, enhance ciliary movement, dissolve mucus, and promote sputum discharge
More
Selective beta-receptor agonists relax bronchial smooth muscles, enhance ciliary movement, dissolve mucus, and promote sputum discharge |
21898-19-1 | 14 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Lactulose |
Lactulose is not absorbed in the small intestine, and only a small part of the acidic metabolites produced by its decomposition in the colon are absorbed. This leads to increased osmotic pressure in the intestinal cavity, retention of water and electrolytes, increased intestinal volume, mechanical stimulation to the intestinal wall, and chemical stimulation from the acidic metabolites, resulting in laxative effects.
More
Lactulose is not absorbed in the small intestine, and only a small part of the acidic metabolites produced by its decomposition in the colon are absorbed. This leads to increased osmotic pressure in the intestinal cavity, retention of water and electrolytes, increased intestinal volume, mechanical stimulation to the intestinal wall, and chemical stimulation from the acidic metabolites, resulting in laxative effects. |
667mg | 4618-18-2 | 20 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Finasteride |
This product belongs to the 4-nitrogen steroid hormone compound, which is a specific type II 5α-reductase competitive inhibitor. It inhibits the conversion of peripheral testosterone into dihydrotestosterone and reduces the level of dihydrotestosterone in the blood, prostate, skin and other tissues. The growth, development and benign hyperplasia of the prostate depend on dihydrotestosterone. Finasteride inhibits prostate hyperplasia and improves the related clinical symptoms of benign prostatic hyperplasia by reducing the level of dihydrotestosterone in the blood and prostate tissue.
More
This product belongs to the 4-nitrogen steroid hormone compound, which is a specific type II 5α-reductase competitive inhibitor. It inhibits the conversion of peripheral testosterone into dihydrotestosterone and reduces the level of dihydrotestosterone in the blood, prostate, skin and other tissues. The growth, development and benign hyperplasia of the prostate depend on dihydrotestosterone. Finasteride inhibits prostate hyperplasia and improves the related clinical symptoms of benign prostatic hyperplasia by reducing the level of dihydrotestosterone in the blood and prostate tissue. |
98319-26-7 | 50 |